Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Biodesix (BDSX) Other Gross PP&E Adjustments (2019 - 2026)

Biodesix filings provide 8 years of Other Gross PP&E Adjustments readings, the most recent being $32.9 million for Q1 2026.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 1.95% to $32.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $32.9 million, a 1.95% decrease, with the full-year FY2025 number at $31.9 million, down 3.04% from a year prior.
  • Other Gross PP&E Adjustments hit $32.9 million in Q1 2026 for Biodesix, up from $31.9 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $34.5 million in Q3 2024 to a low of $7.7 million in Q3 2022.
  • Median Other Gross PP&E Adjustments over the past 5 years was $31.9 million (2025), compared with a mean of $25.3 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: tumbled 32.01% in 2022 and later surged 298.05% in 2023.
  • Biodesix's Other Gross PP&E Adjustments stood at $8.3 million in 2022, then soared by 263.17% to $30.0 million in 2023, then grew by 9.49% to $32.9 million in 2024, then decreased by 3.04% to $31.9 million in 2025, then increased by 3.14% to $32.9 million in 2026.
  • The last three reported values for Other Gross PP&E Adjustments were $32.9 million (Q1 2026), $31.9 million (Q4 2025), and $33.7 million (Q3 2025) per Business Quant data.